Literature DB >> 32606155

Osteogenic Evaluation of Hydroxyapatite Scaffold Loaded With Dexamethasone in Femoral Drill Holes.

Min-Ho Park1, Seok Jin Jang2, Seok Hwa Choi3.   

Abstract

BACKGROUND/AIM: Many cases of bone damage are due to trauma and metabolic diseases. This study aimed to evaluate bone regeneration into a porous hydroxyapatite (HA) scaffold using dexamethasone (DM)-loaded polymeric microspheres.
MATERIALS AND METHODS: Four adult dogs were used to evaluate the in vivo performance of DM-loaded microspheres immobilized on the surfaces of porous HA scaffolds. Two 5-mm drill holes were created in both the left and right femurs of each dog. The experimental groups included a control group (drill holes filled with HA scaffold alone), a DM 20 group (holes filled with DM-loaded HA scaffold with 20 mg DM per scaffold), and a DM 100 group (hole filled with DM-loaded HA scaffold with 100 mg DM per scaffold). Resulting bone volume percentages and bone mineral densities were calculated by examing micro-computed tomographic (CT) images.
RESULTS: The DM-loaded HA scaffold groups showed a gradual periosteal reaction two weeks after insertion of the HA scaffold into the femoral drill holes. Four weeks after HA scaffold insertion, the periosteal reaction in the femoral drill holes became denser. Eight weeks after insertion of DM-loaded HA scaffolds, clear images of the scaffold were observed in micro-CT images of the femoral drill hole. The DM 100 group had better bone healing tendencies (bone mineral density, bone mass, trabecular volume, bone surface, and trabecular thickness) than the DM 20 group.
CONCLUSION: DM-loaded HA scaffolds are suitable platforms for distributing bioactive molecules during osteogenesis in femoral drill holes. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Dexamethasone; drill bit; hydroxyapatite; osteogenesis; scaffold

Mesh:

Substances:

Year:  2020        PMID: 32606155      PMCID: PMC7439853          DOI: 10.21873/invivo.11980

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

Review 1.  Mechanisms involved in the side effects of glucocorticoids.

Authors:  Heike Schäcke; Wolf Dietrich Döcke; Khusru Asadullah
Journal:  Pharmacol Ther       Date:  2002-10       Impact factor: 12.310

Review 2.  How to achieve sustained and complete protein release from PLGA-based microparticles?

Authors:  A Giteau; M C Venier-Julienne; A Aubert-Pouëssel; J P Benoit
Journal:  Int J Pharm       Date:  2007-11-17       Impact factor: 5.875

3.  Routine use of dexamethasone for postoperative nausea and vomiting: the case for.

Authors:  P S Kakodkar
Journal:  Anaesthesia       Date:  2013-07-15       Impact factor: 6.955

4.  Routine use of dexamethasone for postoperative nausea and vomiting: the case against.

Authors:  R Bartlett; A J Hartle
Journal:  Anaesthesia       Date:  2013-07-15       Impact factor: 6.955

5.  Glucocorticoids suppress bone formation via the osteoclast.

Authors:  Hyun-Ju Kim; Haibo Zhao; Hideki Kitaura; Sandip Bhattacharyya; Judson A Brewer; Louis J Muglia; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

6.  Fabrication and characterization of porous hydroxyapatite granules.

Authors:  D M Liu
Journal:  Biomaterials       Date:  1996-10       Impact factor: 12.479

7.  Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.

Authors:  Jun Sik Son; Mark Appleford; Joo L Ong; Joseph C Wenke; Jong Min Kim; Seok Hwa Choi; Daniel S Oh
Journal:  J Control Release       Date:  2011-03-21       Impact factor: 9.776

8.  Single-dose dexamethasone reduces dynamic pain after total hip arthroplasty.

Authors:  Kenneth J Kardash; Frederic Sarrazin; Michael J Tessler; Ana M Velly
Journal:  Anesth Analg       Date:  2008-04       Impact factor: 5.108

9.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.

Authors:  S L Cheng; J W Yang; L Rifas; S F Zhang; L V Avioli
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

10.  Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells.

Authors:  Hyongbum Kim; Hyun Woo Kim; Hwal Suh
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

View more
  1 in total

1.  Evaluation and comparison of synthesised hydroxyapatite in bone regeneration: As an in vivo study.

Authors:  Alireza Rahimnia; Hamid Hesarikia; Amirhosein Rahimi; Shahryar Karami; Kamran Kaviani
Journal:  J Taibah Univ Med Sci       Date:  2021-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.